News Alphabet spinout SandboxAQ buys Good Chemistry Two years after spinning out of the Google parent Alphabet, quantum computing and artificial intelligence specialist SandboxAQ has bought one of its smaller rivals in a de
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.